PHIO PHARMACEUTICALS CORP. Preferred Stock, Liquidation Preference, Value
PHIO PHARMACEUTICALS CORP. (PHIO) had Preferred Stock, Liquidation Preference, Value of $0 as of 2013-12-31, per its 10-K filed 2014-03-28.
Discontinued › Balance Sheet › Equity
us-gaap:PreferredStockLiquidationPreferenceValue · last filed 2014-03-28
- 2013-12-31: Preferred Stock, Liquidation Preference, Value $0.00.
- 2012-09-30: Preferred Stock, Liquidation Preference, Value $9.57M.
- 2012-06-30: Preferred Stock, Liquidation Preference, Value $9.42M.
| Period end | Preferred Stock, Liquidation Preference, Value |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-28 |
| 2012-09-30 | $9.57M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $9.42M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |